CRC Tier 1
CRC Tier 1
批准号:
256391
负责人:
Laupacis Andreas
金额:
$101.99万
依托单位:
依托单位国家:
加拿大
项目类别:
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-04-01 至 2018-04-01
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Xylitol for the prevention of otitis media in young children: a pragmatic randomized controlled trial
-
批准号:284994
-
项目类别:Operating Grants
-
资助金额:$1.46万
-
财政年份:2013
-
负责人:Laupacis Andreas
-
依托单位:
Systematic reviews of the evidence that tests for chronic cerebrospinal venous insufficiency (CCSVI) are valid and reproducible, that CCSVI is associated with multiple sclerosis, and of the benefits and harms of endovascular therapy for multiple sclerosis
-
批准号:252386
-
项目类别:Operating Grants
-
资助金额:$7.23万
-
财政年份:2012
-
负责人:Laupacis Andreas
-
依托单位:
Determining the research priorities of Canadian dialysis patients, caregivers and clinicians
-
批准号:264135
-
项目类别:Miscellaneous Programs
-
资助金额:$1.82万
-
财政年份:2012
-
负责人:Laupacis Andreas
-
依托单位:
healthydebate.ca: Increasing public knowledge about, and participation in, health care policy
-
批准号:235774
-
项目类别:Miscellaneous Programs
-
资助金额:$6.93万
-
财政年份:2011
-
负责人:Laupacis Andreas
-
依托单位:
People Power: Harnessing Public Wisdom to Improve Health Care
-
批准号:236891
-
项目类别:Miscellaneous Programs
-
资助金额:$0.22万
-
财政年份:2011
-
负责人:Laupacis Andreas
-
依托单位:
Systematic reviews of the evidence that tests for chronic cerebrospinal venous insufficiency (CCSVI) are valid and reproducible, that CCSVI is associated with multiple sclerosis, and of the benefits and harms of endovascular therapy for multiple sclerosis
-
批准号:223220
-
项目类别:Operating Grants
-
资助金额:$7.23万
-
财政年份:2011
-
负责人:Laupacis Andreas
-
依托单位:
Health in All Policies: A Scoping Review
-
批准号:198021
-
项目类别:Operating Grants
-
资助金额:$8.01万
-
财政年份:2009
-
负责人:Laupacis Andreas
-
依托单位:
A Virtual Ward to Reduce Readmissions after Hospital Discharge
-
批准号:196725
-
项目类别:Operating Grants
-
资助金额:$25.49万
-
财政年份:2009
-
负责人:Laupacis Andreas
-
依托单位:
海外基金